Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Shiratori

Showing results (61-70 of 247) with videos related to

Pageof 25
Sort By:
Journal of Hepatology|January 1, 1990
Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophagesY Shiratori, M Tanaka, J Umihara, et al.
Internal Medicine (Tokyo, Japan)|May 25, 1999
Acquired factor VIII inhibitor in a non-hemophilic patient with chronic hepatitis C viral infectionK Sugishita, H Nagase, T Takahashi, et al.
International Immunology|August 1, 1995
Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host diseaseT Tanaka, Y Ohtsuka, H Yagita, et al.
Radiology|February 7, 2001
Pancreas and peripancreatic vessels: effect of imaging delay on gadolinium enhancement at dynamic gradient-recalled-echo MR imagingM Kanematsu, Y Shiratori, H Hoshi, et al.
Acta Pathologica Japonica|March 1, 1984
Electron microscopic studies on IgA nephropathyM Kimura, I Sato, Y Shiratori, et al.
Gastroenterologia Japonica|December 1, 1989
Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxinY Shiratori, H Moriwaki, Y Muto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatomaH Moriwaki, I Yasuda, Y Shiratori, et al.
Hepatology (Baltimore, Md.)|February 1, 1990
Role of endotoxin-responsive macrophages in hepatic injuryY Shiratori, M Tanaka, K Hai, et al.
Journal of Virology|October 29, 1997
Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activatorN Kato, K H Lan, S K Ono-Nita, et al.
Methods in Molecular Medicine|February 23, 2011
Adenovirus-mediated drug-sensitivity gene therapy for hepatocellular carcinomaF Kanai, M Ohashi, P A Marignani, et al.
Pageof 25

Showing results (61-70 of 247) with videos related to

Sort By:
Pageof 25
Journal of Hepatology|January 1, 1990
Leukotriene inhibitors modulate hepatic injury induced by lipopolysaccharide-activated macrophagesY Shiratori, M Tanaka, J Umihara, et al.
Internal Medicine (Tokyo, Japan)|May 25, 1999
Acquired factor VIII inhibitor in a non-hemophilic patient with chronic hepatitis C viral infectionK Sugishita, H Nagase, T Takahashi, et al.
International Immunology|August 1, 1995
Involvement of alpha 1 and alpha 4 integrins in gut mucosal injury of graft-versus-host diseaseT Tanaka, Y Ohtsuka, H Yagita, et al.
Radiology|February 7, 2001
Pancreas and peripancreatic vessels: effect of imaging delay on gadolinium enhancement at dynamic gradient-recalled-echo MR imagingM Kanematsu, Y Shiratori, H Hoshi, et al.
Acta Pathologica Japonica|March 1, 1984
Electron microscopic studies on IgA nephropathyM Kimura, I Sato, Y Shiratori, et al.
Gastroenterologia Japonica|December 1, 1989
Production of leukotriene B4 in parenchymal and sinusoidal cells of the liver in rats treated simultaneously with D-galactosamine and endotoxinY Shiratori, H Moriwaki, Y Muto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
Deletion of serum lectin-reactive alpha-fetoprotein by acyclic retinoid: a potent biomarker in the chemoprevention of second primary hepatomaH Moriwaki, I Yasuda, Y Shiratori, et al.
Hepatology (Baltimore, Md.)|February 1, 1990
Role of endotoxin-responsive macrophages in hepatic injuryY Shiratori, M Tanaka, K Hai, et al.
Journal of Virology|October 29, 1997
Hepatitis C virus nonstructural region 5A protein is a potent transcriptional activatorN Kato, K H Lan, S K Ono-Nita, et al.
Methods in Molecular Medicine|February 23, 2011
Adenovirus-mediated drug-sensitivity gene therapy for hepatocellular carcinomaF Kanai, M Ohashi, P A Marignani, et al.
Pageof 25